142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Decreasing Health Disparities using the JuxtopiaŽ Imhotep Open-Wear Platform: A Health Enterprise Zone Perspective

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 1:10 PM - 1:30 PM

Christopher Rogers , JuxtopiaŽ Imhotep, Baltimore, MD
Mr. Christopher Rogers will present a unique perspective for measurably decreasing health disparities using wearables derived from the Juxtopia® Imhotep Open-Wear Platform. Mr. Rogers will present information about the West Baltimore, Maryland Health Enterprise Zone (HEZ); Health disparities that adversely impact the 86,000 HEZ population across four zip codes; and how low-cost wearable telehealth devices, created by Juxtopia® Imhotep Open-Wear, may track HEZ population health and interpret, in real-time, data that provides early evidence of population risk factors of health disparities.   Furthermore, Mr. Rogers will discuss state and federal policies that motivate the use of wearables to prevent health disparities.

Learning Areas:

Communication and informatics

Learning Objectives:
Describe how wearable technology may be used to decrease disparities. Define how and what state and federal policies motivate using wearables for decreasing health disparities.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been a health policy professional working on multiple projects focusing on reducing health disparities, increasing access to quality care, and improving health outcomes of diverse and underserved populations. My focus is on critical policy topics including Medicare, Medicaid, health information technology, community health workers, mental health, prescription drug policy, hospital readmissions, quality, and access to care.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.